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METHODS

Blood sampling and analysis
Plasma cardiac troponin I (cTnI) concentrations were measured using the Abbott Architect
Stat high-sensitivity cTnI assay (Abbott Laboratories, Abbott Park, Il, USA). The lower limit of detection of this assay is 1.2 ng/L whilst the 99 th centile from the reference population is 16ng/L for females and 34ng/L for males. We have previously shown that the analytical variability of the Architect Stat assay is low with a coefficient of variation for duplicate samples of 10% at 6 ng/L. 1 Brain natriuretic peptide (BNP) concentrations were measured using the Triage BNP assay (Biosite, Inc., San Diego, CA, USA). The inter-assay coefficient of variation was 10% at 28.8 pg/mL, with a detection range of 5-1300 pg/mL. 2 Table S1 . Magnetic resonance and echocardiographic definitions of six patterns of left ventricular adaption in aortic stenosis.
Asymmetric wall thickening on both modalities was defined by a maximal wall thickness ≥13 mm that was also ≥1.5-fold the thickness of the opposing myocardial segment.
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RESULTS
Study Population Characteristics
In the patient group, 34 (20%) had mild, 45 (27%) moderate, and 87 (53%) severe aortic stenosis. The mean peak aortic jet velocity and aortic valve area were 3.80.9 m/s and 1.00.4cm 2 respectively. Among patients with aortic stenosis, 4 (2%) had an ejection fraction <50% (45±2%). Overall 112 (67%) patients had a history of hypertension (mean systolic blood pressure 151±21 mmHg), 25 (15%) had diabetes mellitus and 59 (35%) had coronary artery disease (Table S2 ).
Left Ventricular Characteristics of Patients with Aortic Stenosis
Compared to controls, patients with aortic stenosis had increased maximum wall thickness measurements Table S8 . Hazard ratios predicting adverse events (aortic valve replacement or deaths) for variables, which were used to construct the models, presented in Table S7 in unadjusted analysis. Figure S1 . Further examples of asymmetric wall thickening on magnetic resonance (A-F) and echocardiography (G-I).
